Withdrawal Notice: HealthLINE - A Chatbot Designed to Aid Self-Management of Chronic Conditions
-
September 7, 2026
September 7, 2026
September 7, 2026
Nirmatrelvir–ritonavir for up to 25 days failed to improve cognitive, autonomic, or exercise symptoms compared with placebo in a phase 2 trial.
September 4, 2026
Investigators compared intra-articular microbial profiles and predicted metabolic pathways in patients with hip osteoarthritis and nonarthritic controls.
September 4, 2026